| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Butterfly Network, Inc.$7.98
-0.12 (-1.5%)
F 16Pipeline Score MedTech · Commercial
Market Cap
1.08 B
EPS
-0.30
P/E Ratio
-15.25 $
Value Trade
17.03 M
SEC Financials
Q1 2026Dilution Risk
Revenue
26.53 M
R&D Expenses
9.54 M
Operating CF
-13.89 M
Total Assets
285.92 M
Total Liabilities
94.70 M
Equity
191.22 M
D/E Ratio
12,345
11.47 %
Week
-19.46 %
1 Month
50 %
3 Month
88.61 %
6 Month
-57.59 %
5 Year
-56 %
All Time
Cash Data
Cash Position
137.95 M
Monthly Burn
4.63 M
Runway
27.7 mo
Burn Trend
SEC Filing
Apr 30, 2026
Overview
Volume
5.38 M
52 Week Range
1.32 - 5.72
% held by Insiders
20.73 %
% held by Institutions
51.26 %
Enterprise Value
957.38 M
Total Shares
261.51 M
Short %
13.42 %
Float Shares
214.18 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Butterfly Network, Inc.
1Total events
0Upcoming
0Tier-1 (high impact)
2026 – 2026Coverage
Event history 1
Jul 2, 2026
▲Other Regulator MilestoneEx-US Regulatory
Expansion of handheld ultrasound availability into Brazil
Drug Pipeline Intelligence
F16
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 14%
Micro Cap (rank 784 of 911)
Percentile RankButterfly Network, Inc. has significant pipeline risk (16/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in BFLY
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
BFLY Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2028-01-21 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2028-01-21 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2028-01-21 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
BFLYButterfly Network Expands its Handheld Ultrasound Availability into Brazil
Butterfly Network has announced the expansion of its handheld ultrasound devices into Brazil. This move aims to enhance access to advanced medical imaging technology in the region. The initiative is expected to significantly improve healthcare delivery and patient outcomes in Brazil.
Read more →BFLY▲ +10.8%on this news
Butterfly Network’s Embedded™ Partner Aleph Neuro Unveils Stunning Brain Images
Butterfly Network's partner, Aleph Neuro, has introduced impressive brain imaging technology. This development highlights advancements in neuroimaging capabilities. The article emphasizes the significance of these images in understanding brain health and potential applications in medical diagnostics.
Read more →BFLY▲ +55.9%on this news
Butterfly Network Provides Commentary on Midjourney Medical’s Full Body Ultrasound Scanner Announcement
Butterfly Network has commented on the announcement made by Midjourney Medical regarding their full body ultrasound scanner. The details of this commentary are not specified in the provided text. The context suggests a focus on advancements in ultrasound technology, but further information is needed for a comprehensive understanding.
Read more →BFLY▲ +5.4%on this news
Butterfly Network to Participate in TD Cowen’s Medical Devices Emerging Growth Call Series on June 18, 2026
Butterfly Network is set to participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026. This event will provide an opportunity for the company to discuss its innovations and growth prospects in the medical devices sector. Further details about the event and participation specifics have not been disclosed.
Read more →BFLYButterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
Butterfly Network is set to participate in the William Blair 46th Annual Growth Stock Conference. This event is an opportunity for the company to showcase its innovations and engage with investors. Further details about their presentation or agenda have not been disclosed.
Read more →BFLYButterfly Network Appoints Caroll H. Neubauer to Board of Directors
Butterfly Network has appointed Caroll H. Neubauer to its Board of Directors. This strategic move is aimed at enhancing the company's leadership and governance. Neubauer brings extensive experience in the healthcare industry, which could benefit Butterfly Network's future initiatives.
Read more →BFLY▼ -6.8%on this newsshared move
Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference
Butterfly Network, Inc. will present at the Bank of America Securities 2026 Global Healthcare Conference on May 12, 2026. CEO Joseph DeVivo and CFO John Doherty will lead the presentation and host investor meetings. The event highlights Butterfly's advancements in ultrasound technology and its commitment to accessible healthcare solutions.
Read more →BFLYButterfly Network Reports First Quarter 2026 Financial Results
Butterfly Network, Inc. reported strong financial results for Q1 2026, achieving a 25% revenue growth year-over-year. The company highlighted improvements in gross margins and successful product rollouts, including an FDA-cleared AI tool. Despite a net loss, Butterfly remains focused on expanding its market presence and enhancing its technology platform.
Read more →BFLYButterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS
Butterfly Network has appointed Arun Nagdev, MD, as Chief Medical Officer for its Point-of-Care Ultrasound (POCUS) division. Dr. Nagdev will be responsible for leading the global medical strategy, which includes advancing clinical product validation and enhancing customer engagement. This strategic move aims to bolster the company's position in the POCUS market.
Read more →BFLY▲ +8.8%on this newsshared move
Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026
Butterfly Network has announced that it will report its financial results for the first quarter of 2026 on April 30, 2026. This announcement is part of the company's regular financial reporting schedule. Further details regarding the results will be provided at that time.
Read more →BFLYButterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women’s Health
Butterfly Network has achieved its first FDA clearance for a new AI tool designed for blind sweep ultrasound imaging. This marks a significant advancement in technology aimed at improving women's health. The tool is expected to enhance diagnostic capabilities and streamline ultrasound procedures.
Read more →BFLY▲ +50.6%on this news
Butterfly Network Reports Fourth Quarter 2025 Financial Results
Butterfly Network reported strong financial results for Q4 2025, with record revenue of $31.5 million, marking a 41% year-over-year growth. The company achieved its first positive operating cash flow quarter, driven by increased U.S. sales and strategic partnerships. However, international revenue saw a decline of 6%, and operating expenses rose by 22%. Overall, the company is transitioning into a semiconductor-based entity focused on AI-driven imaging solutions.
Read more →BFLYButterfly Network to Participate at TD Cowen 46th Annual Health Care Conference on March 3, 2026
Butterfly Network, Inc. will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026, in Boston. Key executives will present and hold one-on-one investor meetings. The presentation will be available via webcast on the company's investor website. Butterfly is known for its innovative ultrasound technology and has received multiple accolades for its contributions to healthcare.
Read more →BFLYButterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications
Butterfly Network, Inc. has announced that its Butterfly iQ+/iQ3 and Compass AI ultrasound solutions have received GovRAMP and TX-RAMP Authorizations. These certifications allow the company to provide cloud services to state and local government agencies, particularly in Texas. This achievement underscores Butterfly's commitment to security and compliance, enhancing its credibility in the healthcare sector.
Read more →BFLYButterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Butterfly Network, Inc. will report its fourth quarter and full year 2025 financial results on February 26, 2026. The announcement includes a conference call hosted by CEO Joseph DeVivo and CFO John Doherty to discuss financial performance. The call will be accessible via a live webcast and will also have a telephone replay available until March 5, 2026.
Read more →BFLY▼ -8.1%on this news
Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth o f at least 17%Year over Year The company will present a business update at the 44th J.P. Morgan Healthcare Conference on
Butterfly Network, Inc. reported a preliminary revenue growth of at least 17% year-over-year for the fourth quarter of 2025. Company executives expressed confidence in continuing strong performance as they enter 2026, with plans to outline strategies and growth expectations at the upcoming J.P. Morgan Healthcare Conference. The company is evolving towards becoming a semiconductor leader while maintaining its innovative approach in portable ultrasound technology.
Read more →BFLY▲ +14.2%on this news· ran to +41% by day 1
Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference
Butterfly Network, Inc. will participate in the 8th Annual Evercore Healthcare Conference, with CEO Joseph DeVivo and CFO Megan Carlson leading a fireside chat and one-on-one investor meetings. The event is scheduled for December 2, 2025, in Coral Gables, FL. A live webcast will be available for those unable to attend in person.
Read more →BFLY▲ +31.9%on this news· ran to +43% by day 1
Butterfly Network Reports Third Quarter 2025 Financial Results Delivered quarterly revenue of $21.5 million in Q3, representing 5% YoY growth. Reduced quarterly cash burn to $3.9 million, a new record low for quarterly c
Butterfly Network, Inc. reported its third quarter financial results for 2025, revealing a revenue of $21.5 million, a 5% increase compared to the same quarter last year. The company achieved a record low cash burn of $3.9 million while reaffirming its full year revenue guidance and narrowing adjusted EBITDA expectations. However, despite revenue growth, Butterfly faced a notable increase in net loss to $34 million and a negative GAAP gross margin of -17.5%. The development of innovative healthcare technologies and strategic initiatives are positioned to enhance the company's market presence going forward.
Read more →BFLYDocument Butterfly Network Appoints John Doherty as Chief Financial Officer Seasoned finance leader brings over 25 years of leadership experience driving growth and transformation
Butterfly Network, Inc. has appointed John Doherty as Chief Financial Officer effective December 8, 2025. Doherty brings over 25 years of financial leadership experience from major companies in the technology sector, including Kaltura and Magic Leap. The company's interim CFO, Megan Carlson, will return to her role as Chief Accounting Officer. The appointment is part of Butterfly's strategy to enhance growth and shareholder value as they enter a new phase marked by a stronger balance sheet and positive momentum in product launches.
Read more →BFLY▼ -18.1%on this news
Butterfly Network Reports Second Quarter 2025 Financial Results Delivered Highest Quarterly Revenue and Gross Margins in Company History Quarterly Revenue of $23.4 million in Q2, representing 9% YoY growth, and Gross Mar
Butterfly Network reported its Q2 2025 financial results, featuring the highest quarterly revenue of $23.4 million and gross margins reaching 64%. The company also showed progress in cash conservation, reducing cash expenditures to $7.1 million. Despite these achievements, Butterfly still reported a net loss of $13.8 million, yet revised its revenue guidance upward for the fiscal year. The company continues to innovate and expand its product offerings while navigating a competitive market landscape.
Read more →BFLYButterfly Network Reports First Quarter 2025 Financial Results Delivered on Quarterly Revenue and EBITDA Guidance Reiterate full year Revenue and Adjusted EBITDA guidance Quarterly Revenue of $21.2 million in Q1, represe
Butterfly Network, Inc. announced strong financial results for Q1 2025, with revenue reaching $21.2 million, marking a 20% increase year-over-year. The company significantly reduced its net loss by 36% and improved its cash position through a public offering that raised $81.7 million. Additionally, ongoing initiatives in medical education and the pilot program for congestive heart failure have shown promising early results. The company's strategic focus appears to be paying off, as it reaffirmed its full-year revenue and EBITDA guidance.
Read more →BFLYButterfly Network Reports Fourth Quarter 2024 Financial Results Delivered Record Annual and Quarterly Revenue Delivered quarterly record Revenue of $22.4 million in Q4, representing 35% YoY growth Reduced Q4 Net Loss by
Butterfly Network, Inc. reported strong financial results for Q4 2024, achieving record revenue of $22.4 million, a 35% increase year-over-year. The company significantly reduced its net loss by 59%, reflecting improved operational efficiency. Notable achievements included a successful capital raise of $81.7 million and the positive preliminary findings from a study demonstrating the benefits of their ultrasound technology in managing congestive heart failure. As Butterfly enters 2025, it aims to accelerate growth with a focus on making ultrasound technology more accessible in various healthcare settings.
Read more →BFLYButterfly Network Announces Pricing of $75.6 million Public Offering of Common Stock 1/29/2025 BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE) - Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digita
Butterfly Network, Inc. has announced the pricing of a public offering of 24 million shares of its Class A common stock at $3.15 per share, aiming to raise approximately $75.6 million. The company plans to use the proceeds for product development, commercialization, and general corporate purposes. The offering is set to close on January 31, 2025, pending customary closing conditions. Bookrunners for the offering include TD Cowen, William Blair, and Lake Street Capital Markets.
Read more →BFLYButterfly Network Announces Proposed Public Offering of Common Stock 1/29/2025 BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE) - Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company
Butterfly Network, Inc. has announced a proposed underwritten public offering of its Class A common stock to fund product development and other corporate purposes. The offering includes a provision for underwriters to purchase an additional 15% of shares. The company aims to leverage the proceeds for enhancing its digital imaging technology. However, the completion of the offering remains contingent upon prevailing market conditions and other unspecified factors.
Read more →BFLYButterfly Network Reports Preliminary, Unaudited Fourth Quarter 2024 Revenue Growth of Approximately 35% Year over Year The Company will present a business update at the 43rd J.P. Morgan Healthcare Conference on
Butterfly Network, Inc. announced an expected revenue growth of about 35% year-over-year for the fourth quarter of 2024. This preliminary, unaudited result suggests strong performance and momentum as the company heads into 2025. The CEO highlighted the importance of exceptional execution and products in achieving this growth. However, the revenue estimate is subject to change pending the completion of their financial closing procedures, with the final audited results due later in February.
Read more →BFLY▲ +14%on this news· ran to +44% by day 3
Butterfly Network Reports Third Quarter 2024 Financial Results Delivered Quarterly Revenue of $20.6mm, 33% YoY Growth Raises Full Year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $20.6 million in
Butterfly Network, Inc. reported its Q3 2024 financial results, highlighting a 33% year-over-year revenue growth to $20.6 million. The company also achieved a reduced net loss of $16.9 million and decreased operating expenses by 30% year-over-year. Improved guidance for full-year revenue and adjusted EBITDA reflects strong execution and future growth potential. Despite the positive financial indicators, the company noted a decline in gross margin and ongoing net losses.
Read more →BFLY▼ -8.2%on this news
Butterfly Network Reports Second Quarter 2024 Financial Results Reports Record Quarterly Revenue Raises Full Year Adjusted EBITDA Guidance Delivered record quarterly Revenue of $21.5 million in Q2, representing 16% YoY g
Butterfly Network, Inc. reported a record quarterly revenue of $21.5 million for Q2 2024, representing a 16% year-over-year growth. The company raised its full year adjusted EBITDA guidance following the successful launch of its next-generation ultrasound technology, the Butterfly iQ3. Despite achieving strong overall revenue growth, U.S. sales faced challenges related to prior-year grant deployments. The company is swiftly enhancing its market reach through new initiatives, solidifying its leadership in the ultrasound market.
Read more →BFLYButterfly Network Reports First Quarter 2024 Financial Results Achieves 14% Revenue Growth - Exceeding Expectations Raises Full Year Guidance Delivered record first quarter Revenue of $17.7 million Reduced Net Loss by 35
Butterfly Network, Inc. has reported a strong financial performance for the first quarter of 2024, achieving a record revenue of $17.7 million, up 14% from the previous year. The company reduced its net loss by 35% and announced an increase in guidance for the fiscal year, reflecting growing confidence in its business trajectory following the launch of its new product, the iQ3. However, the company also faced a notification from the NYSE regarding non-compliance with its listing standards due to stock price concerns.
Read more →BFLYButterfly Network Reports Fourth Quarter 2023 Financial Results Completed Cost Savings and New Initiatives Position Butterfly for Growth Delivered $65.9 million of Revenue - better than expectations Launched next generat
Butterfly Network, Inc. reported its fourth quarter 2023 financial results, highlighting a revenue of $16.5 million, which is a decline compared to the previous year. Despite this, the company achieved cost savings and launched its third-generation ultrasound system, the iQ3, which is set to enhance its market presence. The net loss increased, driven by write-downs and operational challenges, but management is optimistic about growth prospects moving forward. The company aims to strengthen international markets and expand its product offering through innovative technology and partnerships.
Read more →BFLY▲ +19.4%on this news· ran to +38% by day 1
Butterfly Network Reports Third Quarter 2023 Financial Results Delivers on Multiple Growth Initiatives Announced 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Launche
Butterfly Network, Inc. announced its financial results for the third quarter of 2023, highlighting a significant reduction in losses and strategic growth initiatives. Despite a decline in total revenue compared to the previous year, the company emphasized successful partnerships, including a new collaboration with Forest Neurotech. The company also made strides in improving its gross profit margins while implementing cost-saving measures. However, international sales saw a significant drop, affecting overall revenue figures.
Read more →BFLYButterfly Network Reports Second Quarter 2023 Financial Results Reports reorganization with a new plan to extend cash runway and invest in near-term growth opportunities Burlington, MA, and New York, NY
Butterfly Network, Inc. reported its financial results for the second quarter of 2023, showing a revenue decline year-over-year but highlighting significant progress in reorganizing operations. The company reduced operating expenses by approximately 28.5% and aims to extend its cash runway with a revised strategy focused on growth. While the U.S. market saw a 21% increase in sales, international performance suffered a substantial decline. Looking ahead, the company projects revenues of at least $64 million for the year, with adjusted EBITDA losses expected to decrease.
Read more →BFLY▼ -19.3%on this news
Butterfly Network Reports First Quarter 2023 Financial Results Reports revenue in-line with guidance while reducing cash operating expense by 30% Burlington, MA, and New York, NY
Butterfly Network, Inc. announced its financial results for Q1 2023, reporting total revenue of $15.5 million, which was consistent with guidance but slightly down from the previous year. The company managed to reduce cash operating expenses by 30%, contributing to a gross profit increase. However, it also experienced a significant decline in product revenue and reported a net loss of $33.5 million, although an improvement from the previous year's loss. CEO Joe DeVivo highlighted the company's vision to democratize medical imaging despite ongoing market challenges.
Read more →BFLYButterfly Network Names Joseph M. DeVivo as President and Chief Executive Officer Health Tech Executive Brings More Than 35 Years of Business Experience and Operational Excellence to Butterfly - BURLINGTON, MA
Butterfly Network, Inc. has appointed Joseph M. DeVivo as its new President and CEO, effective immediately. DeVivo, with over 35 years of experience in leadership roles within healthcare and medical device companies, is expected to contribute to the company's mission of transforming care through handheld ultrasound technology. His previous successes include significant revenue growth and successful company acquisitions. The announcement comes alongside the company's recent clearance of an AI-enabled product, marking a pivotal moment in their product development strategy.
Read more →BFLYGRANTED IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE BUTTERFLY NETWORK, INC. ) ) C.A. No. 2023-0225- LWW [PROPOSED] FINAL ORDER AND JUDGMENT WHEREAS, this Court having reviewed the Verified Petition for Relief
The Delaware Court of Chancery has granted the Verified Petition for Relief filed by Butterfly Network, Inc., validating the company's new Certificate of Incorporation and the shares issued based on it. The court has determined that the new certificate is effective retroactively as of February 12, 2021. This ruling validates over 164 million shares of Class A and over 26 million shares of Class B common stock, officially resolving the case and closing the action. The ruling follows similar precedents set in other cases regarding Section 205 of the Delaware General Corporation Law.
Read more →BFLY▲ +10.8%on this news
Butterfly Network Reports Fourth Quarter 2022 Financial Results Progress on key initiatives sets the stage for 2023 Burlington, MA., and New York, NY
Butterfly Network, Inc. (BFLY) announced its financial results for Q4 2022, reporting flat total revenue of $19.0 million year-over-year. Despite a decline in product revenue, there was an increase in software and services revenue. The company expects strong revenue growth for 2023 and has successfully implemented cost-saving measures to reduce cash outlay significantly. However, they continue to face challenges, including a net loss increase compared to the previous year.
Read more →BFLYIN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE BUTTERFLY NETWORK, INC. ) C.A. No. 2023-____-___ ) VERIFIED PETITION FOR RELIEF PURSUANT TO 8 DEL. C. 205 Petitioner Butterfly Network, Inc. (f/k/a Longview Acquisi
Butterfly Network, Inc. has filed a petition in the Delaware Court of Chancery seeking validation of its Second Amended and Restated Certificate of Incorporation. This action arises from concerns that the recent court ruling in Garfield v. Boxed, Inc. may undermine the legality of its corporate amendments. The company argues that these amendments, which included an increase in authorized shares, were properly adopted but now face legal scrutiny regarding their approval process. As a result, Butterfly Network is attempting to mitigate potential harms from this legal uncertainty.
Read more →BFLY▼ -17.7%on this news
Butterfly Network Reports Third Quarter 2022 Financial Results Record Revenue with Momentum in Both Health Systems and Software Burlington, MA., and New York, NY
Butterfly Network Reports Third Quarter 2022 Record Revenue with Momentum in Both Health Systems and Software Burlington, MA., and New York, NY, November 3, 2022 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, w
Read more →BFLY▲ +16.5%on this news
Butterfly Network Reports Second Quarter 2022 Financial Results Record Revenue with Momentum in Both Domestic and International Markets GUILFORD, Conn., and
Butterfly Network Reports Second Quarter 2022 Record Revenue with Momentum in Both Domestic and International Markets GUILFORD, Conn., and NEW YORK, August 3, 2022 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld,
Read more →BFLY▼ -6.4%on this news· ran to -19% by day 3
Butterfly Network Reports First Quarter 2022 Financial Results Solid Revenue Growth Driven by Increasing Demand Momentum in Both Human Healthcare and Veterinary Markets GUILFORD, Conn., and
Butterfly Network Reports First Quarter 2022 Solid Revenue Growth Driven by Increasing Demand Momentum in Both Human Healthcare and Veterinary GUILFORD, Conn., and NEW YORK, May 5, 2022 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transformi
Read more →BFLYButterfly Network Names Heather Getz as Chief Financial Officer Health Tech Executive Brings 25 years of Financial and Operational Experience to Butterfly GUILFORD, Conn. and
Butterfly Network Names Heather Getz as Chief Health Tech Executive Brings 25 years of Financial and Operational Experience to Butterfly GUILFORD, Conn. and NEW YORK, April 20, 2022 - Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handhe
Read more →BFLY▲ +5.4%on this news
Butterfly Network Reports Third Quarter 2021 Financial Results Year-over-Year Revenue Growth of 44% Driven by Commercial Expansion GUILFORD, Conn., and
Butterfly Network Reports Third Quarter 2021 Year-over-Year Revenue Growth of 44% Driven by Commercial Expansion GUILFORD, Conn., and NEW YORK, November 15, 2021 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), an innovative digital health company that is working to dem
Read more →BFLY▲ +5.4%on this news
Butterfly Network Reports Fourth Quarter and Full Year 2021 Financial Results Full Year 2021 Revenue Growth of 35% Positive Momentum Driving a New Standard of Care with Butterfly GUILFORD, Conn., and
Butterfly Network Reports Fourth Quarter and Full Year 2021 Financial Results Full Year 2021 Revenue Growth of 35% Positive Momentum Driving a New Standard of GUILFORD, Conn., and NEW YORK, February 28, 2022 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital he
Read more →BFLY▲ +5.4%on this news
Butterfly Network Reports First Quarter 2021 Financial Results Strong Revenue Growth Driven by Increased Demand for Butterfly Network's Solution Gross Margin Above 50% and Adjusted Gross Margin Above 45% Reflecting Benef
Butterfly Network Reports First Quarter 2021 Strong Revenue Growth Driven by Increased Demand for Butterfly Network's Solution Gross Margin Above 50% and Adjusted Gross Margin Above 45% Reflecting Benefits of the New Butterfly iQ+ Supply Chain GUILFORD, Conn., and NEW YORK,
Read more →BFLY▲ +5.4%on this news
Butterfly Network Reports Second Quarter 2021 Financial Results Strong Revenue Growth Driven by Broad Customer Adoption Gross Margin of 49.8% and Adjusted Gross Margin of 50.2% GUILFORD, Conn., and
Butterfly Network Reports Second Quarter 2021 Strong Revenue Growth Driven by Broad Customer Gross Margin of 49.8% and Adjusted Gross Margin GUILFORD, Conn., and NEW YORK, August 9, 2021 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), an innovative digital health compa
Read more →BFLY▲ +5.4%on this news
Butterfly Network, Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021 GUILFORD, Conn. &
Butterfly Network, Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021 GUILFORD, Conn. & NEW YORK, January 11, 2022 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"or the "Company"), a digital health company transforming care with next generation,
Read more →BFLY▲ +5.4%on this news
Butterfly Network Announces Key Appointments to the Board and Management Dr. Erica Schwartz joins Butterfly's Board of Directors Troy Quander joins Butterfly as Senior Vice President, Regulatory and Quality GUILFORD, Con
Butterfly Network Announces Key Appointments to the Board and Management Dr. Erica Schwartz joins Butterfly's Troy Quander joins Butterfly as Senior Vice President, Regulatory and Quality GUILFORD, Conn. & NEW YORK, September 9, 2021 -- Butterfly Network, Inc. (NYSE: BFLY)
Read more →BFLY▲ +5.4%on this news
Legacy Butterfly BFLY Operations, Inc. (formerly known as Butterfly Network, Inc.) Unaudited Quarterly Financial Results for 2020 Butterfly Network, Inc. (the "Company") is furnishing the following tables which set forth
BFLY Operations, Inc. (formerly known as Butterfly Network, Inc.) Unaudited Quarterly Financial Results for 2020 Butterfly Network, Inc. (the "Company") is furnishing the following tables which set forth supplemental unaudited financial information of BFLY Operations, Inc. (
Read more →BFLY▼ -5%on this news· ran to -21% by day 3
Butterfly Network Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Butterfly Network, Inc.
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Butterfly Network, Inc. f/k/a/ Longview Acquisition Corp. (“Butterfly” or the “Company”) (NYSE: BFLY). A complaint has been filed on beha
Read more →BFLYButterfly Network, Inc. Reports 2020 Financial Results Strong Year-Over-Year Revenue Growth Driven by Continued Adoption of Butterfly Technology Highlights Reported 2020 revenues of $46.3 million compared to $27.6 millio
Butterfly Network, Inc. Reports 2020 Financial Strong Year-Over-Year Revenue Growth Driven by Continued Adoption of Butterfly Technology GUILFORD, Conn. and NEW YORK, New York, March 29, 2021 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital he
Read more →BFLYButterfly Network, Inc. Further Strengthens Management and Board with Key Additions Stacey Pugh joins Butterfly as Chief Commercial Officer Dr. Elazer Edelman joins Butterfly's Board of Directors GUILFORD, Conn. and NEW
Butterfly Network, Inc. Further Strengthens Management and Board with Key Additions Stacey Pugh joins Butterfly as Chief Commercial Dr. Elazer Edelman joins Butterfly's GUILFORD, Conn. and NEW YORK, New York, March 11, 2021 Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"),
Read more →BFLYButterfly Network, a Global Leader in Democratizing Medical Imaging, Closes Business Combination and Will Begin Trading on the New York Stock Exchange Announces unaudited 2020 full-year revenue of at least $45 million, r
Butterfly Network, a Global Leader in Democratizing Medical Imaging, Closes Business Combination and Will Begin Trading on the New York Stock Exchange GUILFORD, Conn. and NEW YORK, February 16, 2021 /PRNewswire/ - Butterfly Network, Inc. ("Butterfly" or the "Company") (NYSE:
Read more →BFLYUNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Defined terms included below have the same meaning as terms defined and included elsewhere in the Current Report on Form 8-K (the " Form 8-K ") filed with the
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Defined terms included below have the same meaning as terms defined and included elsewhere in the Current Report on Form 8-K (the "Form 8-K") filed with the Securities and Exchange Commission (the "SEC") on February
Read more →BFLYButterfly Network, Inc. and Longview Acquisition Corp. Announce Dr. Todd Fruchterman to Become President and CEO of the Combined Company - Dawn Carfora, John Hammergren, Gianluca Pettiti and S. Louise Phanstiel to be nom
Butterfly Network, Inc. and Longview Acquisition Corp. Announce Dr. Todd Fruchterman to Become President and CEO of the Combined Company GUILFORD, Conn. and NEW YORK, New York, Jan. 25, 2021 Network, Inc. ("Butterfly"), an innovative digital health company that is working to e
Read more →BFLYButterfly Network, a global leader in democratizing medical imaging, to be listed on NYSE through a merger with Longview Acquisition Corp. Butterfly Network's mission is to enable universal access to superior medical ima
Network, a global leader in democratizing medical imaging, to be listed on NYSE through a merger with Longview Acquisition Corp. Butterfly Network's mission is to enable universal access to superior medical imaging, making high quality ultrasound affordable, easy-to-use, global
Read more →BFLYLongview Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing
Longview Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing July 13, 2020 New York, July 10, 2020 - Longview Acquisition Corp. (NYSE: LGVW.U) (the "Company") announced that, commencing July 13, 2020, holder
Read more →BFLYLONGVIEW ACQUISITION CORP. PRO FORMA BALANCE SHEET Actual as of
LONGVIEW ACQUISITION CORP. PRO FORMA BALANCE SHEET Actual as of May 26, 2020 Pro Forma Adjustments June 9, 2020 Pro Forma Adjustments June 26, 2020 As Adjusted as of May 26, 2020 (Unaudited) (Unaudited) (Unaudited) ASSETS Current Assets
Read more →BFLYLONGVIEW ACQUISITION CORP. INDEX TO FINANCIAL STATEMENTS PAGE Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of
LONGVIEW ACQUISITION CORP. INDEX TO FINANCIAL STATEMENTS PAGE Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of May 26, 2020 F-3 Notes to Balance Sheet F-4 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board
Read more →BFLYButterfly Network Announces the World’s First Augmented Reality Telemedicine Technology
GUILFORD, Conn., March 24, 2018 (GLOBE NEWSWIRE) -- Butterfly Network Inc. announced today that it has developed a novel augmented reality telemedicine technology on Butterly iQ™, the world’s first whole-body ultrasound imager. Butterfly iQ is a personal ultrasound device and se
Read more →BFLYButterfly Network Announces Over $100M in Financing to Bring Together Novel Devices, Deep Learning and Cloud Computing to Transform Medicine
SAN FRANCISCO, CALIF., Nov. 3, 2014 (GLOBE NEWSWIRE) -- 4Combinator, a healthcare startup incubator, announced today that its first company, Butterfly Network, has raised over $100 million to transform medical imaging and non-invasive surgery by leveraging advances in semiconduct
Read more →Competitive Position
How BFLY ranks across every disease it competes inCompetitive Position is a premium feature
See how BFLY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial